- Home
- ETHZ vs BCYC Comparison
ETHZ vs BCYC Comparison
Compare ETHZ & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETHZ
- BCYC
- Stock Information
- Founded
- ETHZ N/A
- BCYC 2009
- Country
- ETHZ United States
- BCYC United Kingdom
- Employees
- ETHZ N/A
- BCYC N/A
- Industry
- ETHZ Biotechnology: Pharmaceutical Preparations
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- ETHZ Health Care
- BCYC Health Care
- Exchange
- ETHZ Nasdaq
- BCYC Nasdaq
- Market Cap
- ETHZ 465.0M
- BCYC 492.1M
- IPO Year
- ETHZ N/A
- BCYC 2019
- Fundamental
- Price
- ETHZ $2.31
- BCYC $7.16
- Analyst Decision
- ETHZ
- BCYC Buy
- Analyst Count
- ETHZ 0
- BCYC 12
- Target Price
- ETHZ N/A
- BCYC $22.91
- AVG Volume (30 Days)
- ETHZ 30.2M
- BCYC 260.4K
- Earning Date
- ETHZ 10-26-2025
- BCYC 10-30-2025
- Dividend Yield
- ETHZ N/A
- BCYC N/A
- EPS Growth
- ETHZ N/A
- BCYC N/A
- EPS
- ETHZ N/A
- BCYC N/A
- Revenue
- ETHZ N/A
- BCYC $19,281,000.00
- Revenue This Year
- ETHZ N/A
- BCYC N/A
- Revenue Next Year
- ETHZ N/A
- BCYC $0.27
- P/E Ratio
- ETHZ N/A
- BCYC N/A
- Revenue Growth
- ETHZ N/A
- BCYC N/A
- 52 Week Low
- ETHZ $0.66
- BCYC $6.10
- 52 Week High
- ETHZ $17.75
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- ETHZ N/A
- BCYC 44.32
- Support Level
- ETHZ N/A
- BCYC $6.75
- Resistance Level
- ETHZ N/A
- BCYC $7.64
- Average True Range (ATR)
- ETHZ 0.00
- BCYC 0.32
- MACD
- ETHZ 0.00
- BCYC 0.02
- Stochastic Oscillator
- ETHZ 0.00
- BCYC 44.09
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.